Improving Access to Rare Disease Therapy through Better Patient Data

Bringing therapies to market for rare disease can be a major challenge. The small populations often necessitate unique payer, channel, and patient services strategies. For many pharmaceutical manufacturers, finding a suitable partner with this level of expertise can be a challenge.

This case study highlights how IntegriChain delivered payer data solutions to help the manufacturer identify and resolve obstacles to patient access. As their market access needs evolved to contracting, channel, and gross-to-net, IntegriChain has the optimal solution. Download below!